Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Shared genetic risk factors across carbamazepine-induced hypersensitivity reactions.

Nicoletti P, Barrett S, McEvoy L, Daly AK, Aithal G, Lucena MI, Andrade RJ, Wadelius M, Hallberg P, Stephens C, Bjornsson ES, Friedmann P, Kainu K, Laitinen T, Marson A, Molokhia M, Phillips E, Pichler W, Romano A, Shear N, Sills G, Tanno LK, Sawle A, Floratos A, Shen Y, Nelson MR, Watkins PB, Daly MJ, Morris AP, Alfirevic A, Pirmohamed M.

Clin Pharmacol Ther. 2019 May 7. doi: 10.1002/cpt.1493. [Epub ahead of print]

PMID:
31066027
2.

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study.

Fahim C, Kim BW, Bourcier M, Glassman S, Gooderham M, Guenther L, Gulliver W, Lynde C, Poulin Y, Pratt M, Shear N, Vender R, Walsh S, Fahim S.

J Cutan Med Surg. 2019 May/Jun;23(3):282-288. doi: 10.1177/1203475419833605. Epub 2019 Mar 10.

PMID:
30854878
3.

Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study.

Ighani A, Georgakopoulos JR, Zhou LL, Walsh S, Shear N, Yeung J.

J Cutan Med Surg. 2018 May/Jun;22(3):290-296. doi: 10.1177/1203475418755982. Epub 2018 Jan 26.

PMID:
29373924
4.

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

McCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, Becker F, Rau S, Avbersek A, Heggeli K, Leu C, Depondt C, Sills GJ, Marson AG, Auce P, Brodie MJ, Francis B, Johnson MR, Koeleman BPC, Striano P, Coppola A, Zara F, Kunz WS, Sander JW, Lerche H, Klein KM, Weckhuysen S, Krenn M, Gudmundsson LJ, Stefánsson K, Krause R, Shear N, Ross CJD, Delanty N; EPIGEN Consortium;, Pirmohamed M, Carleton BC; Canadian Pharmacogenomics Network for Drug Safety;, Cendes F, Lopes-Cendes I, Liao WP, O'Brien TJ, Sisodiya SM; EpiPGX Consortium;, Cherny S, Kwan P, Baum L; International League Against Epilepsy Consortium on Complex Epilepsies;, Cavalleri GL.

Neurology. 2018 Jan 23;90(4):e332-e341. doi: 10.1212/WNL.0000000000004853. Epub 2017 Dec 29. Erratum in: Neurology. 2018 Oct 16;91(16):765.

5.

Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.

Almohideb M, Walsh S, Walsh S, Shear N, Alhusayen R.

Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):604-612. doi: 10.1016/j.clml.2017.06.015. Epub 2017 Jun 19.

PMID:
28711574
6.

Letter to the Editor re: 'Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up'.

Olteanu C, Shear N, Hashimoto R, Dodiuk-Gad RP.

Br J Dermatol. 2017 Nov;177(5):1461-1462. doi: 10.1111/bjd.15734. Epub 2017 Oct 25. No abstract available.

PMID:
28626892
7.

Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.

AbuHilal M, Walsh S, Shear N.

J Cutan Med Surg. 2017 Nov/Dec;21(6):507-512. doi: 10.1177/1203475417716366. Epub 2017 Jun 14.

PMID:
28614957
8.

Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast.

AbuHilal M, Walsh S, Shear N.

J Dermatol Case Rep. 2016 Nov 30;10(3):56-57. doi: 10.3315/jdcr.2016.1232. eCollection 2016 Nov 30.

9.

Oral isotretinoin: ensuring safe use while not limiting access to those who need it.

Tan JK, Shear N.

CMAJ. 2017 Apr 3;189(13):E510. doi: 10.1503/cmaj.732920. No abstract available.

10.

An Atypical Case of Mucocutaneous Blastomycosis in the Greater Toronto Area.

Liu A, Shear N, Wong J, Klieb HBE.

J Cutan Med Surg. 2017 May/Jun;21(3):263-266. doi: 10.1177/1203475416686928. Epub 2017 Jan 4.

PMID:
28300442
11.

Assessing finasteride-associated sexual dysfunction using the FAERS database.

Gupta AK, Carviel J, MacLeod MA, Shear N.

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1069-1075. doi: 10.1111/jdv.14223. Epub 2017 Apr 3.

PMID:
28300347
12.

Qu’est-ce que l’hidradénite suppurée?

Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J.

Can Fam Physician. 2017 Feb;63(2):e86-e93. Review. French.

PMID:
28209697
Free PMC Article
13.

What is hidradenitis suppurativa?

Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J.

Can Fam Physician. 2017 Feb;63(2):114-120. Review.

14.

The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.

AbuHilal M, Walsh S, Shear N.

J Cutan Med Surg. 2016 Nov;20(6):509-516. Epub 2016 May 20. Review.

PMID:
27207350
15.

Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.

AbuHilal M, Walsh S, Shear N.

J Cutan Med Surg. 2016 Jul;20(4):313-6. doi: 10.1177/1203475416631328. Epub 2016 Feb 4.

PMID:
26848145
16.

Impact of Cosmetic Camouflage on the Quality of Life of Children With Skin Disease and Their Families.

Salsberg JM, Weinstein M, Shear N, Lee M, Pope E.

J Cutan Med Surg. 2016 May;20(3):211-5. doi: 10.1177/1203475415595175. Epub 2015 Jul 10.

PMID:
26162859
17.

Insights and advances in chronic urticaria: a Canadian perspective.

Sussman G, Hébert J, Gulliver W, Lynde C, Waserman S, Kanani A, Ben-Shoshan M, Horemans S, Barron C, Betschel S, Yang WH, Dutz J, Shear N, Lacuesta G, Vadas P, Kobayashi K, Lima H, Simons FE.

Allergy Asthma Clin Immunol. 2015 Feb 11;11(1):7. doi: 10.1186/s13223-015-0072-2. eCollection 2015.

18.

Managing skin toxicities related to panitumumab.

Bergman H, Walton T, Del Bel R, Seki JT, Rafii A, Xu W, Koren G, Shear N, Krzyzanowska MK, Howell D, Liu G.

J Am Acad Dermatol. 2014 Oct;71(4):754-9. doi: 10.1016/j.jaad.2014.06.011. Epub 2014 Jul 29.

PMID:
25085331
19.

Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.

Bailey K, McKee D, Wismer J, Shear N.

J Cutan Med Surg. 2013 Nov-Dec;17(6):414-8. Review.

PMID:
24138979
20.

Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatments.

Papp K, Guenther L, Shear N, Binder C, Tan J, Lynde C, Gulliver W, Stang P.

J Cutan Med Surg. 2013 May-Jun;17(3):189-96. Review.

PMID:
23673302

Supplemental Content

Loading ...
Support Center